ArticleCancers2021

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy.

Ulrich Krafft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.